ShuYu Civilian Pharmacy Corp., Ltd. (SHE:301017)
China flag China · Delayed Price · Currency is CNY
12.80
-0.45 (-3.40%)
At close: Nov 17, 2026

SHE:301017 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
10,74910,2259,4879,1227,7095,286
Other Revenue
102.84102.8483.2669.51114.1335.25
10,85210,3279,5709,1917,8235,322
Revenue Growth
9.20%7.91%4.13%17.49%47.00%14.70%
Cost of Revenue
8,0107,6367,1586,5975,5923,806
Gross Profit
2,8422,6912,4122,5942,2311,515
Selling, General & Admin
2,5712,4652,3922,2591,8121,330
Research & Development
----0.05-
Other Operating Expenses
19.3919.420.1419.8116.5712.47
Operating Expenses
2,6012,4892,4262,3021,8491,342
Operating Income
240.65202.29-13.93291.99381.8173.57
Interest Expense
-129.75-126.91-138.88-118.33-73.43-31.98
Interest & Investment Income
14.2510.2412.2313.7911.1813.56
Currency Exchange Gain (Loss)
000.02-0.01--
Other Non Operating Income (Expenses)
-34.45-37.21-35.58-11.96-11.95-25.34
EBT Excluding Unusual Items
90.748.41-176.14175.5307.59129.8
Impairment of Goodwill
---48.88---
Gain (Loss) on Sale of Investments
-23.23104.58.480.070.1124.82
Gain (Loss) on Sale of Assets
23.1526.7122.6510.252.08-0.71
Legal Settlements
----0.61--9.26
Other Unusual Items
-7.89-7.89-19.45-7.610.775.81
Pretax Income
86.1171.73-213.34177.59320.55150.46
Income Tax Expense
36.5254.82-8.3337.5487.336.14
Earnings From Continuing Operations
49.58116.91-205.01140.05233.24114.32
Minority Interest in Earnings
-22.68-2.6816.2-6.99-3.810.6
Net Income
26.9114.23-188.81133.06229.43114.92
Net Income to Common
26.9114.23-188.81133.06229.43114.92
Net Income Growth
----42.00%99.64%-46.88%
Shares Outstanding (Basic)
432408402403403383
Shares Outstanding (Diluted)
432408402403403383
Shares Change
15.16%1.56%-0.37%0.17%5.07%4.47%
EPS (Basic)
0.060.28-0.470.330.570.30
EPS (Diluted)
0.060.28-0.470.330.570.30
EPS Growth
----42.10%90.00%-49.15%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
458.19630.5315.78-38.6437.99100.92
Free Cash Flow Per Share
1.061.540.79-0.100.090.26
Dividend Per Share
0.0450.045-0.0500.1150.073
Dividend Growth
----56.52%57.53%-33.64%
Gross Margin
26.19%26.06%25.21%28.22%28.52%28.47%
Operating Margin
2.22%1.96%-0.15%3.18%4.88%3.26%
Profit Margin
0.25%1.11%-1.97%1.45%2.93%2.16%
Free Cash Flow Margin
4.22%6.11%3.30%-0.42%0.49%1.90%
EBITDA
274.02253.7461.64359.83440.06219.28
EBITDA Margin
2.53%2.46%0.64%3.91%5.63%4.12%
D&A For EBITDA
33.3751.4575.5767.8358.2645.71
EBIT
240.65202.29-13.93291.99381.8173.57
EBIT Margin
2.22%1.96%-0.14%3.18%4.88%3.26%
Effective Tax Rate
42.41%31.92%-21.14%27.24%24.02%
Revenue as Reported
10,85210,3279,5709,1917,8235,322
Advertising Expenses
-30.5331.841.6436.7929.62